Skip to content

Aura Biosciences, Inc. AURA Cash Flow Statement

FY'25FY'24FY'23FY'22
-$106.19M-22.2%-$86.92M-13.8%-$76.41M-30.0%-$58.76M-66.7%
$1.16M-2.8%$1.2M-11.5%$1.35M+14.7%$1.18M+44.7%
$14.32M+22.1%$11.72M+33.6%$8.77M+36.8%$6.41M+178%
-$84.74M-6.2%-$79.81M-25.0%-$63.85M-16.9%-$54.6M-68.5%
$447K-64.3%$1.25M+76.7%$709K-35.2%$1.09M-48.5%
$68.82M
$77.16M+4,737%$1.6M-98.4%$97.29M+1.7%$95.63M
-$85.19M-5.1%-$81.06M-25.6%-$64.56M-15.9%-$55.7M-61.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Aura Biosciences, Inc. generate?
Aura Biosciences, Inc. (AURA) generated -$91.3M in operating cash flow over the trailing twelve months.
What is Aura Biosciences, Inc.'s free cash flow?
After $362.0K of capital expenditures, Aura Biosciences, Inc.'s free cash flow was -$91.6M over the trailing twelve months, down 14.5% year over year.
Where does Aura Biosciences, Inc.'s cash flow data come from?
Every line is extracted from Aura Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.